IP Library Granted Patent US 7,282,361
Granted Patent B2
US 7,282,361 · App. 11/074,995 · Granted Oct 16, 2007

Systems and methods for transgenic and targeted mutagenesis screening

Assignee: Transnetyx, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,282,361
App. No.
11/074,995
Granted
Oct 16, 2007
Kind
B2
Abstract

The present invention provides a method and apparatus for to conduct transgenic and targeted mutagenesis screening of genomic DNA. This invention also provides a system for screening DNA for a designated genetic sequence. The system includes a computer having a processor, memory and web browser, wherein the computer receives instructions concerning the designated genetic sequence and other screening parameter selected from a remote user via a form of electronic communication, and an automatic screening device that analyzes samples of genomic DNA for the designated sequence.

Claims (7)

1. A method to obtain purified mammalian genomic DNA from a mammalian tissue sample using magnetic particles comprising:

(a) treating said mammalian tissue sample to obtain a lysate containing cellular debris including mammalian genomic DNA wherein the step of treating said tissue sample involves treating said tissue sample with a lysis buffer wherein said lysis buffer includes proteinase K under conditions to obtain a lysate;

(b) binding said mammalian genomic DNA to said magnetic particles in the presence of said lysate; and

(c) separating said mammalian genomic DNA from cellular debris using magnetic particles.

2. The method of claim 1 wherein the step of binding said mammalian genomic DNA involves treating said lysate with a binding buffer under conditions to bind said mammalian genomic DNA to said magnetic particles.

3. The method of claim 1 further comprising the step of:

(d) disassociating said mammalian genomic DNA from said magnetic particles.

Assignments (6)
SECURITY INTEREST Recorded Apr 13, 2018
From: TRANSNETYX, INC.
To: ABACUS FINANCE GROUP, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 045536/0318 →
RELEASE OF SECURITY INTEREST Recorded Apr 10, 2018
From: LANDMARK COMMUNITY BANK
To: TRANSNETYX, INC.
Reel/Frame 045496/0474 →
RELEASE OF SECURITY INTEREST Recorded Apr 10, 2018
From: PENINSULA FUND V LIMITED PARTNERSHIP
To: TRANSNETYX, INC.
Reel/Frame 045496/0775 →
SECURITY INTEREST Recorded Apr 30, 2015
From: TRANSNETYX, INC.
To: THE PENINSULA FUND V LIMITED PARTNERSHIP
Reel/Frame 035539/0054 →
SECURITY INTEREST Recorded May 29, 2014
From: TRANSNETYX
To: LANDMARK COMMUNITY BANK
Reel/Frame 033053/0834 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2006
From: HODGE, TIMOTHY A.
To: TRANSNETYX, INC.
Reel/Frame 017773/0839 →
Continuity (3)
Continuation 0994595200 · Sep 4, 2001
Provisional Application 6023037100 · Sep 6, 2000
Related Publication 20050170423A1 · Aug 4, 2005